-+ 0.00%
-+ 0.00%
-+ 0.00%

ALNYLAM ANNOUNCES HEALTH CANADA APPROVAL OF AMVUTTRA® (VUTRISIRAN), THE FIRST AND ONLY RNAI THERAPEUTIC FOR THE TREATMENT OF CARDIOMYOPATHY IN ADULT PATIENTS WITH ATTR AMYLOIDOSIS

路透·12/16/2025 13:01:39

登錄查看新聞詳情